💊
İlaç Sektörü Hisseleri
İlaç Sektörü altında 513 Hisse Senedi
İlaç sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
100
Toplam Hisse
$37.6B
Toplam Piyasa Değeri
İlaç Sektörü Hisseleri
Sayfa 3/6 (Toplam: 513)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| NAGE | Niagen Bioscience Inc | $596.55M | $7.48 | 1.06% |
| SIGA | SIGA Technologies, Inc. | $588.60M | $8.22 | 2.66% |
| CMPX | Compass Therapeutics, Inc. | $586.33M | $4.24 | 4.18% |
| SVRA | Savara Inc. | $582.46M | $3.37 | 1.46% |
| KALV | KalVista Pharmaceuticals, Inc. | $581.02M | $11.50 | 2.62% |
| RGLS | Regulus Therapeutics Inc. | $564.95M | $8.16 | 0.00% |
| CTMX | CytomX Therapeutics, Inc. | $554.11M | $3.36 | 2.61% |
| RGNX | REGENXBIO Inc. | $551.62M | $10.92 | 10.27% |
| ABSI | Absci Corporation | $550.24M | $3.68 | 8.23% |
| SAGE | Sage Therapeutics, Inc. | $544.94M | $8.68 | 0.00% |
| MNPR | Monopar Therapeutics Inc. | $541.85M | $87.82 | 13.02% |
| LXRX | Lexicon Pharmaceuticals, Inc. | $541.46M | $1.49 | 9.15% |
| ZIMV | ZimVie Inc. | $534.78M | $18.96 | 0.16% |
| OCGN | Ocugen, Inc. | $534.04M | $1.71 | 6.56% |
| VRNOF | Verano Holdings Corp. | $528.20M | $1.46 | 5.81% |
| VSTM | Verastem, Inc. | $527.44M | $8.57 | 7.25% |
| GOSS | Gossamer Bio, Inc. | $518.43M | $2.28 | 10.94% |
| CRVS | Corvus Pharmaceuticals, Inc. | $516.38M | $6.93 | 4.41% |
| ARCT | Arcturus Therapeutics Holdings Inc. | $514.58M | $18.95 | 3.71% |
| ESPR | Esperion Therapeutics, Inc. | $509.92M | $2.53 | 3.06% |
| RIGL | Rigel Pharmaceuticals, Inc. | $505.47M | $28.18 | 0.77% |
| ORGO | Organogenesis Holdings Inc. | $502.36M | $3.96 | 1.98% |
| MBX | MBX Biosciences, Inc. Common Stock | $500.87M | $14.91 | 5.99% |
| FULC | Fulcrum Therapeutics, Inc. | $486.28M | $8.99 | 6.55% |
| EBS | Emergent BioSolutions Inc. | $483.89M | $9.07 | 9.66% |
| INBX | Inhibrx Biosciences, Inc. | $470.26M | $32.47 | 7.24% |
| CYRX | Cryoport, Inc. | $465.62M | $9.30 | 6.44% |
| SLDB | Solid Biosciences Inc. | $464.10M | $5.96 | 6.88% |
| ALMS | Alumis Inc. Common Stock | $462.07M | $4.44 | 1.99% |
| ITOS | iTeos Therapeutics, Inc. | $448.68M | $10.15 | 0.20% |
| VREX | Varex Imaging Corporation | $448.63M | $10.81 | 4.25% |
| DRUG | Bright Minds Biosciences Inc. | $448.41M | $63.29 | 3.06% |
| RAPT | RAPT Therapeutics, Inc. | $443.05M | $26.79 | 10.74% |
| CGEM | Cullinan Oncology, Inc. | $437.15M | $7.40 | 4.96% |
| XOMA | XOMA Corporation | $433.11M | $36.43 | 6.04% |
| NGNE | Neurogene Inc. | $431.15M | $30.21 | 4.28% |
| PRTC | PureTech Health plc | $428.09M | $17.60 | 4.09% |
| FDMT | 4D Molecular Therapeutics, Inc. | $415.62M | $8.90 | 6.90% |
| SRDX | Surmodics, Inc. | $409.34M | $28.63 | 0.62% |
| KRRO | Korro Bio, Inc. | $403.53M | $42.97 | 8.07% |
| EOLS | Evolus, Inc. | $397.17M | $6.14 | 1.44% |
| BNTC | Benitec Biopharma Inc. | $391.66M | $14.92 | 5.07% |
| YMAB | Y-mAbs Therapeutics, Inc. | $391.22M | $8.61 | 0.23% |
| DSGN | Design Therapeutics, Inc. | $384.40M | $6.75 | 5.20% |
| LCTX | Lineage Cell Therapeutics, Inc. | $379.07M | $1.66 | 5.14% |
| VIGL | Vigil Neuroscience, Inc. | $375.71M | $8.05 | 0.00% |
| LRMR | Larimar Therapeutics, Inc. | $373.17M | $4.36 | 4.18% |
| RCKT | Rocket Pharmaceuticals, Inc. | $369.03M | $3.42 | 6.81% |
| AURA | Aura Biosciences, Inc. | $367.75M | $5.92 | 1.82% |
| CATX | Perspective Therapeutics, Inc. | $361.25M | $4.87 | 26.04% |
| TOI | The Oncology Institute, Inc. | $354.34M | $3.79 | 3.07% |
| REPL | Replimune Group, Inc. | $353.59M | $4.53 | 2.16% |
| OMI | Owens & Minor, Inc. | $348.37M | $4.51 | 1.53% |
| ALT | Altimmune, Inc. | $345.97M | $3.92 | 2.00% |
| TNYA | Tenaya Therapeutics, Inc. | $342.25M | $2.10 | 3.96% |
| ANNX | Annexon, Inc. | $340.64M | $3.10 | 4.91% |
| OPRX | OptimizeRx Corporation | $335.66M | $18.08 | 1.15% |
| CTNM | Contineum Therapeutics, Inc. Class A Common Stock | $333.13M | $11.88 | 2.30% |
| CAPR | Capricor Therapeutics, Inc. | $324.13M | $7.09 | 6.96% |
| ALDX | Aldeyra Therapeutics, Inc. | $323.65M | $5.39 | 4.94% |
| LYEL | Lyell Immunopharma, Inc. | $317.18M | $16.51 | 12.51% |
| VNDA | Vanda Pharmaceuticals Inc. | $313.76M | $5.31 | 2.57% |
| NMRA | Neumora Therapeutics, Inc. Common Stock | $306.08M | $1.89 | 3.08% |
| ALEC | Alector, Inc. | $305.66M | $3.02 | 3.82% |
| GALT | Galectin Therapeutics Inc. | $302.32M | $4.72 | 0.63% |
| SCPH | scPharmaceuticals Inc. | $302.20M | $5.67 | 0.00% |
| TECX | Tectonic Therapeutic, Inc. | $299.77M | $16.02 | 6.21% |
| SLP | Simulations Plus, Inc. | $297.08M | $14.76 | 6.05% |
| LFMD | LifeMD, Inc. | $292.57M | $6.17 | 5.59% |
| KYTX | Kyverna Therapeutics, Inc. | $286.72M | $6.63 | 6.09% |
| OMER | Omeros Corporation | $285.15M | $4.19 | 8.11% |
| VYGR | Voyager Therapeutics, Inc. | $277.34M | $5.00 | 2.91% |
| ABEO | Abeona Therapeutics Inc. | $274.85M | $5.36 | 5.30% |
| LXEO | Lexeo Therapeutics, Inc. Common Stock | $273.54M | $8.24 | 0.49% |
| ALLO | Allogene Therapeutics, Inc. | $272.90M | $1.23 | 18.54% |
| ZURA | Zura Bio Limited | $269.82M | $4.15 | 7.98% |
| TSVT | 2seventy bio, Inc. | $266.14M | $5.00 | 0.00% |
| VMD | Viemed Healthcare, Inc. | $264.52M | $6.82 | 0.73% |
| INZY | Inozyme Pharma, Inc. | $258.25M | $4.00 | 0.25% |
| PBYI | Puma Biotechnology, Inc. | $257.90M | $5.12 | 1.73% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $257.46M | $1.58 | 10.45% |
| VTYX | Ventyx Biosciences, Inc. | $253.86M | $3.56 | 7.77% |
| AVIR | Atea Pharmaceuticals, Inc. | $249.18M | $3.14 | 0.32% |
| HUMA | Humacyte, Inc. | $247.21M | $1.56 | 4.88% |
| LFCR | Lifecore Biomedical, Inc. | $243.09M | $6.50 | 1.96% |
| THRD | Third Harmonic Bio, Inc. | $242.79M | $5.38 | 0.09% |
| RNAC | Cartesian Therapeutics, Inc. | $242.34M | $9.32 | 7.72% |
| SGMT | Sagimet Biosciences Inc. | $237.93M | $7.67 | 10.96% |
| ENTA | Enanta Pharmaceuticals, Inc. | $235.58M | $11.02 | 3.84% |
| TRDA | Entrada Therapeutics, Inc. | $231.65M | $6.09 | 10.31% |
| FHTX | Foghorn Therapeutics Inc. | $229.51M | $4.06 | 8.14% |
| PYXS | Pyxis Oncology, Inc. | $229.47M | $3.70 | 3.39% |
| SLRN | Acelyrin, Inc. | $229.17M | $2.27 | 0.00% |
| IMRX | Immuneering Corporation | $222.53M | $6.13 | 1.76% |
| CRGX | CARGO Therapeutics, Inc. Common Stock | $216.19M | $4.47 | 0.00% |
| CABA | Cabaletta Bio, Inc. | $212.20M | $2.32 | 18.60% |
| IVVD | Invivyd, Inc. | $211.11M | $1.76 | 6.88% |
| CDXS | Codexis, Inc. | $207.94M | $2.59 | 3.36% |
| SGMO | Sangamo Therapeutics, Inc. | $202.84M | $0.67 | 9.01% |
| ACRS | Aclaris Therapeutics, Inc. | $202.58M | $1.87 | 4.10% |